JPRN-UMIN000028085招募中未知
Japanese Melanoma Study - JMS
Japan Skin Cancer Society0 个研究点目标入组 100,000 人开始时间: 2017年7月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Prospective observational study of Japanese melanoma patients treated with combination therapy using nivolumab and ipilimiumabMelanoma, advancedJPRN-UMIN000031736niversity of Tsukuba100
已完成
不适用
Survey of vulvovaginal melanoma in Japavulvovaginal melanomaJPRN-UMIN000025968Japanese Gynecologic Oncology Group (JGOG) Japanese Skin Cancer Society (JSCS)200
已完成
不适用
Japanese research for patients with non-metastatic castration resistant prostate cancer - enzalutamideon-metastatic castration resistant prostate cancerJPRN-UMIN000018964Kagawa University Faculty of Medicine60
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) ALL-B12: A Multi-Center Phase II/III Study in Children with Newly Diagnosed B-cell Precursor Acute Lymphoblastic LeukemiaB cell precursor Acute Lymphoblastic LeukemiaJPRN-UMIN000009339Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)1,940
已完成
2 期
Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-D05: Phase II Study of Risk Stratified Multi-drug Chemotherapy on Down Syndrome with Newly diagnosed Childhood Acute Myeloid LeukemiaAcute myeloid Leukemia Myelodysplastic syndromeJPRN-UMIN000000989Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)73